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Abstract
Background: Despite guidelines recommending opportunistic chlamydia screening of younger
women, screening rates in some countries remain low. Our aim was to review the evidence for
specific interventions aimed at increasing chlamydia screening rates in primary care.
Methods: A Medline search was conducted for controlled trials that assessed the effectiveness of
interventions aimed at improving chlamydia screening rates in primary health care settings. The
Medline search was done for studies in English published prior to December 2005 using the
following key words: chlamydia, screening, intervention, primary care and GPs. In addition, the
references cited in the articles were reviewed. Studies in English published prior to December 2005
were reviewed.
Results: Four controlled studies met the inclusion criteria – 3 were randomized studies and one
was not. Strategies to increase screening rates included the use of educational packages targeting
primary care physicians and the correction of barriers to screening within clinic systems. In 3
studies, the intervention was associated with an increase in screening rates of between 100% and
276% (p < 0.04). In the fourth study, the intervention was associated with a significant attenuation
in declining screening rates over time (4% versus 34% decline, p = 0.04).
Conclusion: There are only a limited number of randomized or controlled studies that
demonstrate improved chlamydia screening of younger women in primary care.
Background
Chlamydia trachomatis is the most commonly reported
bacterial sexually transmitted infection (STI) in the world
[1]. This is of concern as untreated infection can lead to
serious complications such as pelvic inflammatory dis-
ease, tubal infertility and ectopic pregnancy. Most individ-
uals infected with chlamydia are asymptomatic [2,3], so
screening is necessary to detect cases and to reduce the risk
of complications. Studies suggest that selective screening
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incidence of pelvic inflammatory disease [4,5].
Opportunistic screening of sexually active females less
than 25 years of age for chlamydia in primary care has
been recommended in a number of industrialized coun-
tries [6,8]. In Australia, over 80% of women aged 16–24
years visit a general practitioner (GP) at least once a year
for any reason and most chlamydial infections are diag-
nosed in general practice [9]. However, despite the wide-
spread availability of non-invasive testing methods for
chlamydia and single dose therapy using azithromycin,
chlamydia screening rates have overall remained low [9].
Ostensibly, this reflects barriers to testing that relate to
both patients and health care providers. For instance, ado-
lescents may be reluctant to seek care for their sexual
health because of embarrassment or concerns about their
confidentiality, while health care providers may have lim-
ited awareness of chlamydia as an issue or lack the time,
knowledge and skills to manage and discuss sexual health
issues [10,11]. If any chlamydia screening program is to
be implemented successfully, such potential hurdles need
to be identified and addressed. Preferably, this process
should be evidence based. In this paper, we review studies
aimed at identifying specific interventions to increase
chlamydia screening rates in primary care.
Methods
A Medline search was conducted in January 2006 for pub-
lished, controlled trials – both randomised and non-ran-
domised – that assessed the effectiveness of interventions
aimed at improving chlamydia screening rates in primary
health care settings. The Medline search was done using
the following key words: chlamydia, screening, interven-
tion, primary care and GPs. In addition, the references
cited in the articles were reviewed (Figure 1).
The search was restricted to studies published in English
prior to December 2005. We included studies whose spe-
cific objective was to test any intervention aimed at
increasing chlamydia screening in primary care. The pop-
ulation of interest was patients attending primary care or
general practice settings. Studies lacking a control arm
were excluded. The outcome of interest was whether there
was any difference in age- and sex-specific chlamydia
screening rates when the intervention and control arms
were compared. The selection of studies was undertaken
by 2 of the authors (SG, MYC) with any discrepancies
resolved through discussion and consensus among 3 of
the authors (SG, MYC, CKF).
Results
Using the search words "chlamydia" and "screening",
1,639 articles were identified and the abstracts from these
articles were reviewed. Among these articles were 112
studies that recorded an "intervention". Of these, 13 were
conducted in general practice or primary care. An addi-
tional study was identified through the references of one
of these articles. Of the 14 studies, there were only 4 that
compared screening rates using separate intervention and
control groups (Figure 1). Three of these studies were ran-
domised; one was not.
Various approaches were taken in these 4 studies to
increase chlamydia screening rates (Table 1). In 3 studies,
the intervention was associated with an increase in screen-
ing rates of between 100% and 276% (p < 0.04). In the
fourth study, the intervention was associated with a signif-
icant attenuation in declining screening rates over time
(4% versus 34% decline, p = 0.04).
In a study by Verhoeven et al., a cluster randomised con-
trolled trial was carried out among Belgian GPs to assess
the impact of an short educational package on chlamydia
screening rates among female patients less than 35 years
of age [10]. The interventional package included a short
Search method used to identify controlled studies assessing interventions aimed at increasing chlamydia screening in pri-mary careFigur  1
Search method used to identify controlled studies assessing 
interventions aimed at increasing chlamydia screening in pri-
mary care.
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Table 1: Controlled studies on interventions aimed at improving chlamydia screening in primary care.
Study Setting Intervention (duration of follow-up for testing rates) Design Target population Outcomes in the intervention group Outcomes in the control group P value 
for 
difference
Verhoeven 
et al.10
36 GPs in Antwerp, 
Belgium
Educational package (video and text) on 
communication skills for sexual history taking (15 
weeks)
Cluster 
randomized
Females patients aged 
<35 years
18 GPs. Median no. of females 
appropriately tested per GP = 6
18 GPs. Median no. of females 
appropriately tested per GP = 3
0.035
Shafer et 
al.12
10 Pediatric clinics 
in North Carolina
Multifaceted, system-level changes to clinical 
practice to overcome barriers to chlamydia 
screening (18 months)
Randomized Female patients aged 
14–18 years
5 clinics. 478/1017 (47%) of eligible 
girls screened
5 clinics. 203/1194 (17%) of 
eligible girls screened
<0.001
Armstrong 
et al.13
2 primary health 
centres in Scotland
Introduction of a health advisor to increase 
awareness and to provide training on chlamydia 
screening guidelines (6 months)
Non-
randomized
Males and female 
patients aged 15–24 
years
1 health centre.
No. of chlamydia tests*:
Pre-intervention: 152
Post-intervention: 335
1 health centre.
No. of chlamydia tests*:
Pre-intervention: 336
Post-intervention: 374
0.001
Allison et 
al.14
191 primary care 
physician offices in 
the US
Internet based continuous medical education on 
chlamydia screening (2 years)
Randomized Female patients aged 
16–26 years
95 offices. Screening rates:
Pre-intervention: 16.2%
During intervention: 13.3%
Post-intervention: 15.5%
96 offices. Screening rates:
Pre-intervention: 18.9%
During intervention: 13.0%
Post-intervention: 12.4%
0.044†
*Denominator values are not available. The numbers of tests quoted are for all ages.
†p value is for post intervention differences after adjusting for baseline performance.
BMC Public Health 2007, 7:95 http://www.biomedcentral.com/1471-2458/7/95video on communication skills where a GP offers testing
for chlamydia during a simulated consultation. This was
accompanied by text on communication skills for taking
a sexual history, which included techniques for increasing
patient comfort levels. Eighteen GPs in the intervention
group and 18 in the control group were entered into the
analysis.
Over the 15-week study period, GPs in the intervention
group performed significantly more appropriate screening
tests within recommended guidelines (median of 6
patients per GP) than GPs in the control group (median
of 3 patients per GP, p = 0.035; Table 1).
Shafer et al. undertook a cluster randomized controlled
trial involving paediatric clinics in Northern California.
Ten paediatric clinics were randomly assigned to provide
either usual care (n = 5) or the intervention (n = 5) [12].
Staff at both the intervention and control clinics received
information on chlamydia screening guidelines. In addi-
tion, the intervention clinics introduced a clinical
improvement initiative aimed at overcoming barriers to
chlamydia screening at all levels of clinical practice. This
intervention was based on a model to change practice
which consisted of 4 stages: (1) "engage", (2) "team build-
ing", (3) "redesign clinical practice", and (4) "sustain the
gain".
The first of these stages involved engagement with the
health maintenance organisation's leaders by presenting
evidence showing the gap between current and best prac-
tice with respect to chlamydia screening. In addition,
awareness among clinic staff was raised through a brief
introduction to the intervention and to team building
concepts. The second step consisted of the formation of
adolescent care teams comprised of clinic staff who would
act as champions for the project. These teams completed
a workshop that emphasized skill building and imple-
mentation of a model for practice change. A toolkit was
developed to facilitate incremental changes. This included
a customized clinic flow chart which helped team mem-
bers to identify barriers to and solutions for changing their
practice. It also contained promotional material designed
to raise awareness about screening adolescent girls: logos
on stickers used to cue charts, on buttons worn by staff,
and on pens and posters placed in the intervention clinics.
The third stage of the intervention consisted of monthly
meetings of clinic team members, where chlamydia
screening rates and documentation on encounters with
adolescents were reviewed to assess the effectiveness of
prior incremental measures aimed at boosting screening
rates. Barriers to screening were identified as well as strat-
egies to overcome these. As part of this process, all inter-
vention clinics decided to institute universal urine
specimen collection from all adolescents at clinic registra-
tion, prior to their examination. As part of the final inter-
vention stage, the teams developed performance
indicators (number of visits and chlamydia screening
rates) and customized information infrastructure to assist
in monitoring progress against these.
Over the 18-month study period, significantly more
females aged 14–18 were screened in the intervention
clinics (478 of 1017) compared with the control clinics
(203 of 1194, P < 0.001; Table 1).
In a study by Armstrong et al., the effect on chlamydia test-
ing within a Scottish primary health care centre was exam-
ined following the introduction of a health adviser whose
role it was to raise awareness of chlamydia and to train
staff on chlamydia testing guidelines [13]. The number of
chlamydia tests performed during the 6 month period the
adviser was present (n = 335) was higher than that for the
same 6 month period during the preceding year (n = 152).
For the same 6-month periods, the number of tests per-
formed in a control clinic, where no health adviser was
introduced was 336 and 374 respectively (Table 1).
The change in testing rates in the intervention centre
(120%) was significantly higher than the change in testing
in the control centre (11%, p = <0.001). However,
denominator values – the number of patients actually
seen during those periods – were not provided. Much of
the increase in chlamydia testing seen in the intervention
clinic occurred in patients outside the target age range
(15–24 years), with no increase in actual detection rates.
This was attributed to a deficiency in staff training and
linkage of chlamydia screening with cervical screening,
which led to a tendency towards the testing of older
women.
In a study by Allison et al., 191 primary care physicians
offices in the US were randomized either to an internet-
based continuing medical education (CME) program for
increasing chlamydia screening (n = 95) or to a control
arm (n = 96) [14]. The intervention consisted of 4 CME
modules that were released every 3 months. The modules
emphasized a number of points: that young, sexually
active women are at high risk for asymptomatic infection
that may lead to future serious health consequences; that
recently developed urine-based screening allows diagno-
sis without a pelvic examination; and that infection may
be treated easily and effectively.
The mean chlamydia screening rates in women aged 16–
26 years before, during and after the intervention for the
control offices were 18.9%, 13.0% and 12.4%, respec-
tively. For the intervention offices, they were 16.2%,
13.3%, and 15.5%, respectively (p = 0.044 for post inter-Page 4 of 6
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ance; Table 1). The difference in post intervention
screening rates by study group remained significant when
adjusting for both pre intervention and intra intervention
screening rates using repeated-measures analysis (p =
0.009). Thus, the intervention appeared to forestall the
significant decline in screening rates seen in the control
clinics.
As the authors themselves point out, the effect seen was
remarkable given the limited intensity of the intervention:
each physician completed on average 2.4 CME modules,
each taking an average of 12 minutes to complete. More-
over, the magnitude of the real effect may have been
underestimated given the study design.
Discussion
In this review, we identified 4 published, controlled stud-
ies which assessed the efficacy of interventions aimed at
increasing chlamydia screening in primary care. In all of
these studies, each of which took a different approach to
increasing screening, but all of which primarily targeted
younger females, significant increases in chlamydia
screening rates were associated with the interventions.
Although there are many studies that look at possible
ways of increasing chlamydia screening within health
services, few of these include a control arm, which impor-
tantly allow comparison of screening rates in groups
exposed and not exposed to the intervention.
The strengths and limitations of the studies included in
this review varied substantially. For instance, sample sizes
ranged from the 2 health care centres in the study by Arm-
strong et al. to the 191 physician offices in the study by
Allison et al. In some of these studies, especially that by
Shafer et al., the intervention consisted of multiple meas-
ures, each of which could have potentially influenced
screening rates in their own right, and it is unclear which
of these were in fact the most effective and which in prac-
tice could be dispensed with. Finally, the populations and
health care systems in the study settings varied, so the
extent to which the findings would apply to other settings
is uncertain. Because of the diversity of the interventions
in these studies, meta-analytical pooling of the data was
not possible.
Despite these weaknesses, a range of potentially effective
strategies were identified in these studies. These included
those aimed at: increasing awareness of chlamydia and its
sequelae; improving knowledge of screening guidelines
and non-invasive testing; improving physicians' commu-
nication skills, including sexual history taking; and over-
coming barriers within clinic systems. A number of
methods were used to disseminate information and train-
ing, including written guidelines, video educational pack-
ages, and internet based CME modules.
The question remains as to which of these strategies
should be employed in primary care to increase chlamy-
dia screening. It is not clear which would be the most cost-
effective and feasible, particularly in view of the compet-
ing priorities and time constraints that clinicians invaria-
bly face. While the effect of the intervention seen in the
study by Shafer et al. appeared to be relatively large, the
intensity of measures employed would most likely be dif-
ficult to implement universally. By contrast, the internet
based CME modules used by Allison et al. would be easier
to disseminate, relatively cheap and easily accessible. For
clinicians without internet access, the short educational
package of the type employed by Verhoeven et al. would
be an alternative.
It is notable that the results seen in the study by Allison et
al. differed from that in the other studies in that screening
rates actually fell, albeit to a lesser extent in the interven-
tion arm. The reasons for the overall decline in screening
rates in the study are uncertain; however, they highlight
the fact that screening rates may be influenced or indeed
driven by external factors. For instance, overall screening
rates for chlamydia may be influenced by how aware cli-
nicians and members of the public are for the need for STI
screening [15]. They are also likely to be influenced by the
characteristics of the health systems in which screening is
undertaken, not least by the access to screening available
to people at risk for infection and by factors that affect the
level of access [9]. Any programme aimed at enhancing
chlamydia screening in primary care will need to take such
factors into account.
Aside from the overarching objective of increasing screen-
ing rates, any chlamydia screening programme also needs
to define the target population and how the programme
will be implemented. Guidelines from a number of coun-
tries advocate opportunistic screening of sexually active
young females under the age of 25 when they attend
health services. Such an approach to screening has the
advantage in that it utilizes existing infrastructure and is
therefore less resource intensive than more systematic
approaches such as the registry-based cervical screening
programmes operating in some countries. A systematic
approach to screening is likely to result in higher coverage
with greater health benefits, but at a higher cost, while the
success of opportunistic screening is dependent on ade-
quate levels of awareness and training on the part of
health care providers.
The optimal approach to chlamydia screening, however,
remains uncertain [16]. Whether or not the inclusion of
men into chlamydia screening programmes results inPage 5 of 6
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additional health benefits is also unknown although
modeling suggests that this could be the case [17]. Any
eventual programme should also consider additional
strategies that could enhance chlamydia control such as
measures to facilitate partner notification, testing and
treatment [18].
Conclusion
The findings in this review indicate that there are differing
approaches that can be taken to support primary health
care providers to significantly increase targeted chlamydia
screening of younger women. However, there are really
too few controlled studies to allow any comprehensive
discussion of evidence based options. Given the efforts
that have gone into rolling out chlamydia screening in
various countries and the continuing, low screening rates
that have been observed in some, further randomized,
controlled studies using novel strategies are needed.
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